HealthEquity, Inc.
HQY · NASDAQ
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $1,200 | $1,000 | $862 | $757 |
| % Growth | 20% | 16% | 13.9% | – |
| Cost of Goods Sold | $423 | $377 | $372 | $333 |
| Gross Profit | $777 | $623 | $490 | $424 |
| % Margin | 64.8% | 62.3% | 56.9% | 56% |
| R&D Expenses | $240 | $219 | $193 | $157 |
| G&A Expenses | $132 | $104 | $96 | $84 |
| SG&A Expenses | $223 | $183 | $164 | $143 |
| Sales & Mktg Exp. | $91 | $79 | $69 | $59 |
| Other Operating Expenses | $152 | $0 | $95 | $83 |
| Operating Expenses | $615 | $504 | $452 | $383 |
| Operating Income | $162 | $128 | $39 | $35 |
| % Margin | 13.5% | 12.8% | 4.5% | 4.6% |
| Other Income/Exp. Net | -$46 | -$53 | -$47 | -$43 |
| Pre-Tax Income | $116 | $75 | -$38 | -$67 |
| Tax Expense | $19 | $19 | -$12 | -$22 |
| Net Income | $97 | $56 | -$26 | -$44 |
| % Margin | 8.1% | 5.6% | -3% | -5.9% |
| EPS | 1.11 | 0.65 | -0.31 | -0.53 |
| % Growth | 70.8% | 309.7% | 41.5% | – |
| EPS Diluted | 1.09 | 0.64 | -0.31 | -0.53 |
| Weighted Avg Shares Out | 87 | 86 | 84 | 83 |
| Weighted Avg Shares Out Dil | 89 | 87 | 84 | 83 |
| Supplemental Information | – | – | – | – |
| Interest Income | $14 | $12 | $2 | $2 |
| Interest Expense | $61 | $55 | $48 | $37 |
| Depreciation & Amortization | $162 | $153 | $161 | $137 |
| EBITDA | $338 | $282 | $172 | $103 |
| % Margin | 28.1% | 28.3% | 19.9% | 13.6% |